JP2024546916A5 - - Google Patents

Info

Publication number
JP2024546916A5
JP2024546916A5 JP2024535740A JP2024535740A JP2024546916A5 JP 2024546916 A5 JP2024546916 A5 JP 2024546916A5 JP 2024535740 A JP2024535740 A JP 2024535740A JP 2024535740 A JP2024535740 A JP 2024535740A JP 2024546916 A5 JP2024546916 A5 JP 2024546916A5
Authority
JP
Japan
Prior art keywords
seq
amino acid
acid sequence
polypeptide
isvd
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2024535740A
Other languages
English (en)
Japanese (ja)
Other versions
JP2024546916A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/EP2022/086353 external-priority patent/WO2023111266A1/en
Publication of JP2024546916A publication Critical patent/JP2024546916A/ja
Publication of JP2024546916A5 publication Critical patent/JP2024546916A5/ja
Pending legal-status Critical Current

Links

JP2024535740A 2021-12-17 2022-12-16 TCRαβ、CD33及びCD123を標的とする免疫グロブリン単一可変ドメインを含むポリペプチド Pending JP2024546916A (ja)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
EP21306822 2021-12-17
EP21306822.4 2021-12-17
EP22305477.6 2022-04-07
EP22305477 2022-04-07
PCT/EP2022/086353 WO2023111266A1 (en) 2021-12-17 2022-12-16 POLYPEPTIDES COMPRISING IMMUNOGLOBULIN SINGLE VARIABLE DOMAINS TARGETING TCRαβ, CD33 AND CD123

Publications (2)

Publication Number Publication Date
JP2024546916A JP2024546916A (ja) 2024-12-26
JP2024546916A5 true JP2024546916A5 (cg-RX-API-DMAC7.html) 2025-10-27

Family

ID=84982528

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2024535740A Pending JP2024546916A (ja) 2021-12-17 2022-12-16 TCRαβ、CD33及びCD123を標的とする免疫グロブリン単一可変ドメインを含むポリペプチド

Country Status (10)

Country Link
EP (1) EP4448574A1 (cg-RX-API-DMAC7.html)
JP (1) JP2024546916A (cg-RX-API-DMAC7.html)
KR (1) KR20240122867A (cg-RX-API-DMAC7.html)
AU (1) AU2022409733A1 (cg-RX-API-DMAC7.html)
CA (1) CA3242445A1 (cg-RX-API-DMAC7.html)
CO (1) CO2024008570A2 (cg-RX-API-DMAC7.html)
IL (1) IL313552A (cg-RX-API-DMAC7.html)
MX (1) MX2024007564A (cg-RX-API-DMAC7.html)
TW (1) TW202342508A (cg-RX-API-DMAC7.html)
WO (1) WO2023111266A1 (cg-RX-API-DMAC7.html)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AR134580A1 (es) * 2023-12-08 2026-01-28 Janssen Biotech Inc ANTICUERPOS DE CD33, ANTICUERPOS MULTIESPECÍFICOS DE CD33 / Vd2 Y USOS DE ESTOS

Family Cites Families (42)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE69334275D1 (de) 1992-08-21 2009-05-20 Univ Bruxelles Immunoglobuline ohne Leichtkette
WO1994025591A1 (en) 1993-04-29 1994-11-10 Unilever N.V. PRODUCTION OF ANTIBODIES OR (FUNCTIONALIZED) FRAGMENTS THEREOF DERIVED FROM HEAVY CHAIN IMMUNOGLOBULINS OF $i(CAMELIDAE)
FR2708622B1 (fr) 1993-08-02 1997-04-18 Raymond Hamers Vecteur recombinant contenant une séquence d'un gène de lipoprotéine de structure pour l'expression de séquences de nucléotides.
EP0739981A1 (en) 1995-04-25 1996-10-30 Vrije Universiteit Brussel Variable fragments of immunoglobulins - use for therapeutic or veterinary purposes
ATE374248T1 (de) 1996-06-27 2007-10-15 Vlaams Interuniv Inst Biotech Antikörpermoleküle, die spezifisch mit dem aktiven zentrum oder dem aktiven spalt eines zielmoleküls interagieren
DK1027439T3 (da) 1997-10-27 2010-05-10 Bac Ip Bv Multivalente antigenbindende proteiner
AU3596599A (en) 1998-01-26 1999-08-09 Unilever Plc Method for producing antibody fragments
BR9916765A (pt) 1999-01-05 2001-09-25 Unilever Nv Processo para produzir um material imunoadsorvente, uso de uma proteìna que é ligada por meio de uma ligação covalente a um fragmento de anticorpo, material imunadsorvente, uso de um material, e, kit de teste diagnóstico
ATE276359T1 (de) 1999-01-19 2004-10-15 Unilever Nv Verfahren zur herstellung von antikörperfragmenten
CN1252264C (zh) 1999-04-22 2006-04-19 荷兰联合利华有限公司 利用单价抗原-结合蛋白抑制病毒感染
US6479280B1 (en) 1999-09-24 2002-11-12 Vlaams Interuniversitair Institutuut Voor Biotechnologie Vzw Recombinant phages capable of entering host cells via specific interaction with an artificial receptor
ATE342922T1 (de) 1999-11-29 2006-11-15 Unilever Nv Immobilisierung von proteinen mit hilfe eines polypeptidsegments
ATE440111T1 (de) 1999-11-29 2009-09-15 Bac Ip B V Immobilisierte antigenbindende moleküle aus einer domäne
ATE428733T1 (de) 2000-03-14 2009-05-15 Unilever Nv Variabele domänen der schweren kette eines antikörpers gegen menschliche ernährungslipasen und deren verwendungen
US20030190598A1 (en) 2000-05-26 2003-10-09 Jasmid Tanha Single-domain antigen-binding antibody fragments derived from llama antibodies
AU2002229639A1 (en) 2000-12-13 2002-06-24 De Haard, Johannes Joseph Wilhelmus Camelidae antibody arrays
JP4213586B2 (ja) 2001-09-13 2009-01-21 株式会社抗体研究所 ラクダ抗体ライブラリーの作製方法
JP2005289809A (ja) 2001-10-24 2005-10-20 Vlaams Interuniversitair Inst Voor Biotechnologie Vzw (Vib Vzw) 突然変異重鎖抗体
EP1456410A2 (en) 2001-12-11 2004-09-15 AlgoNomics N.V. Method for displaying loops from immunoglobulin domains in different contexts
JP4323317B2 (ja) 2001-12-21 2009-09-02 フラームス・インテルウニフェルシタイル・インステイチュート・フォール・ビオテヒノロヒー・ヴェーゼットウェー(ヴェーイーベー・ヴェーゼットウェー) 可変領域配列のクローニング方法
WO2003055527A2 (en) 2002-01-03 2003-07-10 Vlaams Interuniversitair Instituut Voor Biotechnologie Vzw Immunoconjugates useful for treatment of tumours
NZ540194A (en) 2002-11-08 2008-07-31 Ablynx Nv Single domain antibodies directed against tumour necrosis factor-alpha and uses therefor
EP1558645B1 (en) 2002-11-08 2011-07-27 Ablynx N.V. Stabilized single domain antibodies in pharmaceutical composition adapted for inhalation
PT1687338E (pt) 2003-11-07 2011-01-20 Ablynx Nv Anticorpos de domínio único vhh de camelídeos direccionados para o receptor do factor de crescimento epidérmico e suas utilizações
WO2006040153A2 (en) 2004-10-13 2006-04-20 Ablynx N.V. Single domain camelide anti -amyloid beta antibodies and polypeptides comprising the same for the treatment and diagnosis of degenarative neural diseases such as alzheimer's disease
JP2008528010A (ja) 2005-01-31 2008-07-31 アブリンクス ナームローゼ フェンノートシャップ 重鎖抗体の可変ドメイン配列を作出する方法
AU2006249144B2 (en) 2005-05-18 2011-11-17 Ablynx Nv Improved NanobodiesTM against Tumor Necrosis Factor-alpha
LT2444424T (lt) 2005-05-20 2018-10-25 Ablynx N.V. Pagerintos tm nanodalelės, skirtos agregacijos sąlygotų sutrikimų gydymui
AU2007237501A1 (en) 2006-04-14 2007-10-25 Ablynx N.V. DP-78-like nanobodies
JP2010500876A (ja) 2006-08-18 2010-01-14 アブリンクス エン.ヴェー. Il−6媒介性シグナル伝達に関連する疾患及び障害の治療のための、il−6rに指向性を有するアミノ酸配列及びこれを含むポリペプチド
CA3141978A1 (en) 2011-06-23 2012-12-27 Ablynx Nv Techniques for predicting, detecting and reducing aspecific protein interference in assays involving immunoglobulin single variable domains
LT3466972T (lt) 2011-06-23 2026-06-25 Ablynx Nv Serumo albuminą surišantys baltymai
LT3248986T (lt) 2014-05-16 2022-03-25 Ablynx Nv Imunoglobulino kintami domenai
HRP20191800T1 (hr) * 2015-05-13 2019-12-27 Ablynx N.V. Polipeptidi koji regrutiraju t stanice koji se temelje na tcr alfa/beta reaktivnosti
HUE057241T2 (hu) 2015-11-13 2022-04-28 Ablynx Nv Javított, szérumalbumint kötõ immunoglobulin variábilis domének
AU2016357460B2 (en) 2015-11-18 2023-07-27 Ablynx Nv Improved serum albumin binders
US11840569B2 (en) 2016-11-16 2023-12-12 Ablynx N.V. T cell recruiting polypeptides capable of binding CD123 and TCR alpha/beta
WO2018104444A1 (en) 2016-12-07 2018-06-14 Ablynx Nv Improved serum albumin binding immunoglobulin single variable domains
EP3571224B1 (en) 2017-01-17 2024-08-07 Ablynx NV Improved serum albumin binders
EP4442709A3 (en) 2017-01-17 2024-12-25 Ablynx NV Improved serum albumin binders
KR20200142525A (ko) * 2018-04-05 2020-12-22 노파르티스 아게 암에 대한 삼중특이성 결합 분자 및 이의 용도
WO2022129637A1 (en) * 2020-12-18 2022-06-23 Ablynx Nv T cell recruiting polypeptides based on tcr alpha/beta reactivity

Similar Documents

Publication Publication Date Title
JP2023504914A5 (cg-RX-API-DMAC7.html)
JP2023553697A5 (cg-RX-API-DMAC7.html)
JP2024063213A5 (cg-RX-API-DMAC7.html)
EP3144320B1 (en) Fc fusion proteins comprising novel linkers or arrangements
JP2020195399A5 (cg-RX-API-DMAC7.html)
JP2023553694A5 (cg-RX-API-DMAC7.html)
JP2020186248A5 (cg-RX-API-DMAC7.html)
JP2020506898A5 (cg-RX-API-DMAC7.html)
JP2020500510A5 (cg-RX-API-DMAC7.html)
JP2023534636A5 (cg-RX-API-DMAC7.html)
JP2019503990A (ja) 改良された血清アルブミン結合剤
JP2020500015A5 (cg-RX-API-DMAC7.html)
JP2018537421A5 (cg-RX-API-DMAC7.html)
JP2020532285A5 (cg-RX-API-DMAC7.html)
JP2025512865A5 (cg-RX-API-DMAC7.html)
JP2024547218A5 (cg-RX-API-DMAC7.html)
JP2017519503A5 (cg-RX-API-DMAC7.html)
JP2024504923A5 (cg-RX-API-DMAC7.html)
CA2560278A1 (en) Modified bouganin proteins, cytotoxins and methods and uses thereof
JP2025504625A5 (cg-RX-API-DMAC7.html)
CN112125975A (zh) Pd-l1和cd47双特异性融合蛋白及其医药用途
JP2025530888A5 (cg-RX-API-DMAC7.html)
JP2024023268A5 (cg-RX-API-DMAC7.html)
JP2024531346A5 (cg-RX-API-DMAC7.html)
KR20240028341A (ko) 융합 폴리펩티드